OnKure Therapeutics, Inc.
Total Trades
11
Buys
1
Sells
10
Largest Trade
$1M+
Insiders
4
Institutional Funds
28
Inst. Value
$1M+
Activist Filings
29
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Saccomano Nicholas A | President and CEO | SELL | <$1K | 87 | $2.97 | Dec 24, 2025 |
| Leverone Jason A. | CFO | SELL | <$1K | 302 | $2.97 | Dec 24, 2025 |
| Saccomano Nicholas A | President and CEO | SELL | <$1K | 88 | $2.62 | Sep 24, 2025 |
| Leverone Jason A. | CFO | SELL | <$1K | 303 | $2.62 | Sep 24, 2025 |
| Saccomano Nicholas A | President and CEO | SELL | <$1K | 88 | $2.38 | Jun 25, 2025 |
| Leverone Jason A. | CFO | SELL | <$1K | 303 | $2.38 | Jun 25, 2025 |
| Cormorant Asset Management, LP | Insider | SELL | $1M+ | 1.8M | $1.85 | May 19, 2025 |
| ACORN BIOVENTURES, L.P. | 10% Owner | BUY | $1M+ | 1.4M | $1.85 | May 19, 2025 |
| Cormorant Asset Management, LP | 10% Owner | SELL | $15K–$50K | 24K | $1.99 | May 14, 2025 |
| Saccomano Nicholas A | President and CEO | SELL | $1K–$15K | 874 | $2.94 | Apr 8, 2025 |
| Leverone Jason A. | CFO | SELL | $1K–$15K | 3K | $2.94 | Apr 8, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 28 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 1.0M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 1.0M | $1M+ | SH |
| Prosight Management, LP | 817K | $1M+ | SH |
| Rosalind Advisors, Inc. | 730K | $1M+ | SH |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 542K | $1M+ | SH |
| NEA Management Company, LLC | 479K | $1M+ | SH |
| CANTOR FITZGERALD, L. P. | 445K | $1M+ | SH |
| Carlyle Group Inc. | 270K | $500K+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 247K | $500K+ | SH |
| Aisling Capital Management LP | 89K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 62K | $100K–$500K | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 60K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 46K | $100K–$500K | SH |
| Aldebaran Capital, LLC | 41K | $100K–$500K | SH |
| MORGAN STANLEY | 25K | $50K–$100K | SH |
| JANE STREET GROUP, LLC | 16K | $15K–$50K | SH |
| WELLS FARGO & COMPANY/MN | 11K | $15K–$50K | SH |
| CITIGROUP INC | 4K | $1K–$15K | SH |
| BARCLAYS PLC | 2K | $1K–$15K | SH |
| BlackRock, Inc. | 2K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 18, 2026
7.9%
1.0M shares
SC 13G/A · Feb 17, 2026
0.4%
49K shares
SC 13G/A · Jan 30, 2026
4.9%
627K shares
SC 13G · Nov 28, 2025
5.8%
746K shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
Highbridge Capital Management, LLC
SC 13G · Aug 14, 2025
5.2%
664K shares
SC 13G · Aug 14, 2025
5.2%
670K shares
SC 13D/A · May 30, 2025
13.3%
1.7M shares
SC 13G · May 29, 2025
6.3%
810K shares
SC 13D · May 22, 2025
13.3%
1.7M shares
Cormorant Asset Management, LP
SC 13G/A · May 19, 2025
0.0%
0 shares
SC 13G/A · Feb 14, 2025
4.1%
524K shares
Highbridge Capital Management, LLC
SC 13G/A · Feb 7, 2025
3.2%
400K shares
SC 13G/A · Feb 7, 2025
1.6%
203K shares
SC 13G · Jan 31, 2025
5.6%
707K shares
SC 13G/A · Nov 14, 2024
2.3%
295K shares
SC 13G/A · Oct 28, 2024
1.8%
225K shares
SC 13G/A · Oct 23, 2024
5.2%
660K shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Oct 16, 2024
3.4%
435K shares
SC 13G · Oct 11, 2024
9.8%
6 shares
Cormorant Global Healthcare Master Fund, LP
SC 13G · Oct 11, 2024
3.9%
493K shares
SC 13G · Oct 11, 2024
6.5%
824K shares
SC 13G · Oct 11, 2024
5.4%
684K shares
SC 13G · Oct 10, 2024
7.9%
1.0M shares
SC 13D/A · Oct 10, 2024
2.2%
27.3M shares
SC 13G · Oct 9, 2024
144.0M shares
SC 13G/A · Oct 9, 2024
2.7%
346K shares
SC 13D/A · Sep 30, 2022
14.0%
3.4M shares